A chemical liquid manufacturing apparatus is provided. The manufacturing apparatus at least includes an ion exchange medium and an ion adsorption medium configured downstream from the ion exchange medium. A material of the ion adsorption medium includes a resin material having an amide bond or an imide bond.

An object of the present invention is to provide a chemical liquid purification method which makes it possible to obtain a chemical liquid having excellent defect inhibition performance. Another object of the present invention is to provide a chemical liquid. The chemical liquid purification method according to an embodiment of the present invention is a chemical liquid purification method including obtaining a chemical liquid by purifying a substance to be purified containing an organic solvent, in which a content of the stabilizer in the substance to be purified with respect to the total mass of the substance to be purified is equal to or greater than 0.1 mass ppm and less than 100 mass ppm.

Provided is a method for manufacturing a long-life brewed alcoholic beverage by a filtration process with the use of a porous membrane involving a washing step, whereby a high tolerance (chemical tolerance) to a washing solution (a chemical solution) and a good filtration performance are achieved. A method for ma manufacturing a second brewed alcoholic beverage which includes: a filtration step for passing a first brewed alcoholic beverage, which contains a yeast and a high-molecular substance or sediment component produced through fermentation by the yeast, through a porous membrane, which is formed of a resin having a three-dimensional network structure, to thereby separate the second brewed alcoholic beverage from the yeast; and a washing step for passing a washing solution through the porous membrane or immersing the porous membrane in the washing solution to thereby wash the inside of the porous membrane.

Embodiments of the present disclosure include systems and methods for enhancing the performance and efficiency of separation processes. The methods include flowing a fluid through a processing zone defined by an antiferromagnetic portion of a conduit and, as the fluid flows through the processing zone, exposing the fluid to a magnetic field produced by oscillating electromagnetic waves, wherein the direction of the magnetic field is generally counter to the direction in which the fluid is flowing. The systems include magnetic treatment units, separation systems, and the like.

In alternative embodiments, provided are compositions, including products of manufacture and kits, and methods, for purifying bacteriophage. Provided herein is are practicable methods, or protocols, that are “Good Laboratory Manufacturing Practice” (GLMP), for phage isolation, selection, liter-scaled cultivation, and purification. In alternative embodiments, GLMP protocols as provided herein employ membrane filtration processes to yield at least about 300 treatment doses at about 10.sup.9 plaque-forming units with endotoxin levels within human therapeutic regulatory limits. In alternative embodiments, provided are formulations or pharmaceutical preparations of bacteriophage comprising 10.sup.9 PFU, 10.sup.10 PFU, 10.sup.11 PFU, or 10.sup.12 PFU or more per unit dose and endotoxin levels below about 5.5 EU.Math.mL.sup.−1, or below about 5.0 EU.Math.mL.sup.−1.

A membrane filter apparatus for splitting a feed into filtrate and retentate is provided. The apparatus comprises a body chamber, a feed inlet disposed on the body chamber, a retentate outlet located in the body chamber, a feed distribution tube connected to the feed inlet, and a filter assembly having a filter. The feed distribution tube has a length sufficient to cause the feed to enter the body chamber at a feed distance from the filter assembly of no greater than 50% of a total length of the body chamber. The feed flows across the filter in a direction parallel to a surface of the filter assembly. The filtrate passes through the filter assembly and the retentate flows through the body chamber in a direction antiparallel to the feed flow through the feed distribution tube and out through the retentate outlet.

The present invention relates to the separation and isolation of sialylated human milk oligosaccharides (HMOs) from the reaction mixture in which they are produced.

A crossflow filtration unit for continuous diafiltration of a feed fluid for obtaining a retentate and a permeate, a corresponding method for diafiltration and the use of the crossflow filtration unit are provided. The crossflow filtration unit includes a diafiltration channel, a flat first filter material, a retentate channel, a flat second filter material, and a permeate collection channel, arranged such that the flat first filter material delimits the diafiltration channel and the retentate channel from one another, and the flat second filter material delimits the retentate channel and the permeate collection channel from one another. The diafiltration channel is fluidly connected to at least one inlet for the diafiltration medium, the retentate channel is fluidly connected to at least one inlet for the feed fluid and to at least one outlet for the retentate. The permeate collection channel is fluidly connected to at least one outlet for the permeate.

A method for preparing a durably hydrophilic and uniform-pore ultrafiltration membrane is disclosed herein. Chemical reactions between the functional groups and the active bonds of the molecular chains in the membrane materials are initiated perform the grafting of hydrophilic chains on the polymer chains under conventional dissolution conditions of the polymer membrane material (dissolution with synchronized hydrophilization), so as to realize durable hydrophilization of the membrane materials. The resulting hydrophilized polymer solution (a nascent-state membrane) is introduced into a coagulation bath to initiate a crosslinking reaction among the hydrophilic chains. The resulting crosslinking serves to synergistically regulate subsequent phase separation and membrane formation (phase separation under synergistic crosslinking).

A method of obtaining a compound may include adding a substrate to a medium in a reactor, and reacting the substrate in the reactor to form the compound. A first stream is separated from the reaction liquid through a first membrane. A second stream is separated from the reaction liquid through a second membrane. The first membrane is a filtration membrane and the second membrane is configured for liquid-gas or liquid-liquid extraction The first membrane and the second membrane are at least partially immersed in the medium and are moved relative to the reactor during the separation steps.